Clough Capital Partners L P Nurix Therapeutics, Inc. Transaction History

Clough Capital Partners L P

  • $924 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$12.94 - $29.65 $6.12 Million - $14 Million
-473,048 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$22.71 - $36.69 $6.91 Million - $11.2 Million
304,248 Added 180.24%
473,048 $14.2 Million
Q2 2021

Aug 16, 2021
BUY
$24.21 - $35.89 $4.09 Million - $6.06 Million
168,800 New
168,800 $4.48 Million

Others Institutions Holding NRIX

# of Institutions
181
Shares Held
68.1M
Call Options Held
78K
Put Options Held
53.8K
View Full List

About Nurix Therapeutics, Inc.

NRIX Quotes by TradingView
  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $935M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Clough Capital Partners L P Portfolio

Follow Clough Capital Partners L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email